Zoster Post‑Herpetic Neuralgia (PHN)
What is Zoster post‑herpetic neuralgia?
Post‑herpetic neuralgia (PHN) is a chronic neuropathic pain syndrome that can develop after an episode of herpes zoster (shingles). The varicella‑zoster virus, which also causes chickenpox, reactivates in sensory nerve ganglia, producing a painful rash. In some individuals, the nerve damage persists long after the rash has healed, leading to persistent burning, stabbing, or throbbing pain that lasts ≥ 90 days after the rash resolution. PHN is the most common complication of shingles and can significantly impair quality of life.
According to the CDC, up to 20 % of people who develop shingles will experience PHN, with risk rising sharply with age (≈ 30 % in individuals > 60 years).
Common Causes
PHN itself is a consequence of nerve injury caused by the varicella‑zoster virus, but several factors increase the likelihood of developing it. The following conditions or situations are most commonly associated with PHN:
- Advanced age – Immune function declines after age 50, making nerve recovery slower.
- Severe acute shingles rash – Extensive dermatomal involvement or vesicles that become ulcerated.
- Delayed antiviral therapy – Starting acyclovir/valacyclovir > 72 hours after rash onset.
- Immunosuppression – HIV infection, chemotherapy, organ transplantation, or chronic steroids.
- Pre‑existing neuropathies – Diabetes mellitus or peripheral neuropathy can exacerbate nerve damage.
- Chronic pain conditions – Fibromyalgia or previous episodes of PHN may sensitize the nervous system.
- Psychological stress – High stress levels can amplify pain perception and hinder healing.
- Smoking – Impairs microvascular blood flow to nerves.
- Vitamin B12 deficiency – Essential for myelin maintenance; deficiency can worsen neuropathic pain.
- Genetic predisposition – Certain HLA types have been linked to more severe herpes‑zoster complications.
Associated Symptoms
While the hallmark of PHN is persistent pain, additional sensory and autonomic changes often accompany it. Common associated symptoms include:
- Allodynia – Pain caused by normally non‑painful stimuli such as light touch or clothing.
- Hyperesthesia – Heightened sensitivity to temperature or pressure.
- Paresthesia – Tingling, “pins‑and‑needles,” or numbness in the affected dermatome.
- Pruritus (itching) – May coexist with burning pain.
- Sleep disturbance – Night‑time pain can lead to insomnia and daytime fatigue.
- Depression or anxiety – Chronic pain is strongly linked to mood disorders.
- Reduced skin integrity – Repeated scratching can cause excoriations or secondary infection.
- Functional limitation – Difficulty performing daily activities that involve the affected area (e.g., reaching, dressing).
When to See a Doctor
Prompt medical evaluation can reduce the severity and duration of PHN. Seek professional care if you notice any of the following:
- The rash of shingles does not begin to crust over within 7–10 days.
- Severe, worsening pain that interferes with sleep or daily activities.
- Allodynia or hyperesthesia that makes routine contact (clothing, bedding) intolerable.
- Signs of secondary infection: increasing redness, warmth, pus, or fever.
- New neurological deficits such as weakness or loss of coordination in the affected area.
- Persistent pain lasting > 90 days after the rash has healed.
Older adults, people with weakened immune systems, and those with a history of chronic pain should contact their clinician as soon as shingles appears, ideally within 72 hours, to start antiviral therapy.
Diagnosis
Diagnosing PHN is primarily clinical, based on a history of recent shingles and ongoing neuropathic pain. The evaluation typically includes:
- Detailed medical history – Onset, location, intensity (often measured with a 0‑10 numeric rating scale), and characteristics of pain.
- Physical examination – Inspection of the healed dermatome, assessment of sensory changes (touch, pin‑prick, temperature).
- Dermatome mapping – Correlates pain distribution with the spinal nerve that was affected during the acute shingles episode.
- Screening questionnaires – Tools like the Neuropathic Pain Scale (NPS) or the Douleur Neuropathique 4 (DN4) help confirm a neuropathic pain component.
- Laboratory tests (optional) – In immunocompromised patients, PCR testing of vesicle fluid or blood can confirm ongoing VZV replication.
- Imaging – Rarely needed, but MRI may be ordered if there is suspicion of alternative diagnoses (e.g., spinal cord compression).
Because PHN is a diagnosis of exclusion, physicians must rule out other causes of chronic dermatomal pain, such as peripheral nerve entrapment, herpes simplex infection, or malignancy.
Treatment Options
Management of PHN aims to reduce pain, improve function, and prevent complications. A multimodal approach—combining pharmacologic, interventional, and self‑care strategies—offers the best outcomes.
Pharmacologic Therapies
- Antivirals – Initiated during acute shingles (acyclovir, valacyclovir, famciclovir) to limit viral replication; they do not treat established PHN but can lessen severity if started early.
- Topical agents
- Capsaicin 8% patch (Qutenza) applied by a clinician for up to 60 minutes; provides analgesia lasting up to 12 weeks.
- Lidocaine 5% plaster (Lidoderm) – applied for up to 12 hours per day, especially useful for localized pain.
- Anticonvulsants – First‑line for neuropathic pain.
- Gabapentin (starting 300 mg TID, titrating to 1800‑3600 mg/day).
- Prenyl‑pregabalin (150‑600 mg/day) – often better tolerated.
- Tricyclic antidepressants (TCAs) – Amitriptyline or nortriptyline (10‑75 mg nightly); effective but contraindicated in patients with cardiac conduction disease.
- Serotonin‑norepinephrine reuptake inhibitors (SNRIs) – Duloxetine or venlafaxine may be useful, especially when depression co‑exists.
- Opioids – Reserved for severe refractory pain; short‑acting formulations only after careful risk‑benefit analysis (CDC guideline).
- Systemic corticosteroids – Not routinely recommended for PHN, but short courses may be considered during the acute phase of shingles to reduce inflammation.
Interventional Procedures
- Epidural steroid injections – May provide temporary relief for thoracic or lumbar dermatomes.
- Peripheral nerve blocks – Targeted lidocaine or bupivacaine injections.
- Spinal cord stimulation (SCS) – Considered for patients with chronic, refractory PHN after exhaustive medical therapy.
- Radiofrequency ablation – Pulsed radiofrequency of the dorsal root ganglion can reduce pain intensity in select cases.
Self‑Care & Lifestyle Measures
- Cold or warm compresses – Applied for short periods can soothe burning sensations.
- Gentle skin care – Use hypoallergenic moisturizers to prevent itching‑induced excoriations.
- Stress‑reduction techniques – Mindfulness, yoga, or guided breathing can lower pain perception.
- Sleep hygiene – Dark, cool bedroom; consider a night‑time analgesic dose of gabapentin if pain disrupts sleep.
- Physical activity – Light stretching or walking improves circulation and reduces stiffness.
Follow‑up and Monitoring
Patients should be re‑evaluated every 4–6 weeks after treatment initiation. Pain scores, functional status, and side‑effects must be documented. Dose adjustments or medication switches are common during the first few months.
Prevention Tips
Because PHN follows shingles, the most effective prevention strategy is to reduce the incidence and severity of shingles itself.
- Shingles vaccination –
- Recombinant zoster vaccine (RZV, Shingrix) – Two-dose series, >90 % efficacy in adults ≥ 50 years (CDC). Preferred over the live attenuated vaccine.
- Adults 19‑49 years with immunocompromise should also receive RZV.
- Prompt antiviral therapy – Initiate acyclovir/valacyclovir within 72 hours of rash onset to shorten the acute episode and lower PHN risk.
- Maintain a healthy immune system – Balanced diet, regular exercise, adequate sleep, and smoking cessation.
- Control chronic conditions – Optimize blood glucose in diabetes, manage hypertension, and treat vitamin B12 deficiency.
- Avoid skin trauma – Reducing mechanical irritation of the rash may lessen nerve irritation.
Emergency Warning Signs
- Sudden, severe, spreading pain accompanied by fever > 101.5 °F (38.6 °C) – possible super‑infection.
- Rapidly worsening neurological deficits (weakness, loss of coordination, vision changes) in the affected limb.
- Signs of an allergic reaction to medication (hives, swelling of the face or throat, difficulty breathing).
- Uncontrollable vomiting or dehydration that prevents you from taking oral medications.
- Severe, unrelenting pain that does not respond to prescribed medications and is impairing breathing or cardiac function.
These symptoms may indicate complications such as bacterial superinfection, meningitis, or a systemic reaction that require urgent care.
Key Take‑aways
- Post‑herpetic neuralgia is a painful, long‑lasting complication of shingles, most common in older adults.
- Early antiviral treatment, vaccination, and control of risk factors dramatically reduce the odds of developing PHN.
- A multimodal treatment plan—topical agents, anticonvulsants, antidepressants, and, when needed, interventional procedures—offers the greatest chance of pain relief.
- Persistent or worsening pain, signs of infection, or new neurological symptoms warrant prompt medical attention.
For personalized advice, always discuss symptoms and treatment options with your health‑care provider. The information above reflects current recommendations from reputable sources such as the Mayo Clinic, CDC, and the NIH.
```